MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Affective Symptom Burden in Individuals with Olfactory Dysfunction in the PREDICT-PD Cohort

    A. Shahid, S. Waters, S. Meyer, H. Chohan, V. Azoidou, C. Simonet, L. Pérez-Carbonell, E. De-Pablo Fernandez, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To investigate associations between hyposmia (olfactory dysfunction) and affective symptom burden in PREDICT-PD participants. Background: Anxiety, depression, and hyposmia are common non-motor features of…
  • 2026 International Congress

    Identification of a sporadic dystonia-related brain network using resting-state fMRI and machine learning

    O. Omilabu, D. Truong, K. Nguyen, S. Vacca, T. Fitzpatrick, A. Oh, M. Neithammer, N. Nguyen, D. Eidelberg, A. Vo (Great Neck, USA)

    Objective: To identify and characterize sporadic dystonia-related network (SDRN) using resting-state fMRI (rs-fMRI) and machine learning. Background: Sporadic dystonia is a hyperkinetic movement disorder characterized by…
  • 2026 International Congress

    The Unholy Marriage Between Ogilvie Syndrome and Parkinson’s Disease

    Y. Zashchypas, S. Lorenzl (Salzburg, Austria)

    Objective: To demonstrate the dynamic interplay between advanced Parkinson’s disease (PD)–related colonic dysmotility and acute colonic pseudo-obstruction (ACPO; Ogilvie syndrome) and to highlight practical red…
  • 2026 International Congress

    Association of one-year group-based telerehabilitation with quality of life in Parkinson’s disease

    H. Saegusa, S. Okusa, T. Nukariya, T. Tezuka, Y. Nihei, Y. Kitagawa, S. Kubo, Y. Terayama, N. Suzuki, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: To examine changes in quality of life (QoL) over 1 year in Parkinson’s disease (PD) patients participating in group-based telerehabilitation (TR), and to explore…
  • 2026 International Congress

    Deep brain stimulation improves levodopa-induced dyskinesias beyond medication reduction in Parkinson’s disease

    C. Reyes, C. Martínez, J. Fonseca, F. Castro, A. Calderón, L. Reyes, C. Ramírez (Ciudad de México, Mexico)

    Objective: To determine whether the improvement in levodopa-induced dyskinesias after deep brain stimulation is primarily associated with reduction in dopaminergic medication or with a direct…
  • 2026 International Congress

    Intranasal spray for nose-to-brain drug delivery: Emergency treatment of OFF episodes in Parkinson’s disease

    Y. Tang, X. Yue, E. Liang, C. Wu (Guangzhou, China)

    Objective: To evaluate a novel nose-to-brain nasal spray (XJN010) for emergency treatment of OFF episodes in Parkinson's disease (PD) via clinical pharmacokinetics, safety, and tolerability.…
  • 2026 International Congress

    Oral Frailty in Patients with Parkinson’s Disease: A Cross-Sectional Study Using the OF-5 Checklist

    S. Ueno, R. Kurisaki, Y. Oike, A. Fujimoto, M. Nakao, K. Harada, M. Toda, C. Nagatoshi, N. Tawara, M. Ishizaki, Y. Nishida, Y. Maeda (Koshi, Japan)

    Objective: To investigate the prevalence of oral frailty (OF) in patients with Parkinson’s disease (PD) and to explore its clinical examine correlates. Background: The concept…
  • 2026 International Congress

    Translating Real-World Parkinsonian Facial Kinematics onto Diverse Digital Avatars

    C. Gundler, A. Wiederhold, M. Pötter-Nerger (Hamburg, Germany)

    Objective: To support the development of a smart textile with facial sensors and present a novel continuous monitoring approach, we derived and rendered digital twins…
  • 2026 International Congress

    Levodopa–Entacapone–Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: a Four-Year Real-Life Experience

    J. Szasz, V. Constantin, K. Orban Kis, R. Szasz, S. Bataga, R. Neagoe, M. Ciorba, K. Kelemen, I. Mihaly, K. Biro, S. Szatmari (TARGU MURES, Romania)

    Objective: To describe the improvement of motor complications in patients with advanced Parkinson’s Disease (APD) treated with Levodopa-Entacapone-Carbidopa Intestinal Gel (LECIG). Background: The continuous enteral…
  • 2026 International Congress

    Fracture Burden and Health-Related Quality of Life in Older Adults with Parkinson’s Disease in Rural India: A Community-Based Study

    B. Kuanar, D. Panda (Bhubaneswar, India)

    Objective: This study aimed to examine the relationship between fracture history and health-related quality of life (HRQoL) among elderly individuals with Parkinson’s disease residing in…
  • 1
  • 2
  • 3
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley